Northwest Medical Specialties Hematology/Oncology

Tacoma, Washington 98405

0 studies enrolling now · 2 studies all time

What they study most

PI3K Pathway Activated Tumors, Tumor Pathway Activations Inhibited by Dovitinib

Studies at this site

• BKM120 for Patients With PI3K-activated Tumors — Completed
• Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib — Completed